← Back to Clinical Trials
Recruiting NCT06289660

NCT06289660 Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06289660
Status Recruiting
Phase —
Sponsor Meyer Children's Hospital IRCCS
Condition Tuberculosis Infection
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2022-12-22
Primary Completion 2033-01-02

Eligibility & Interventions

Sex All sexes
Min Age 1 Week
Max Age 18 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2022-12-22 with a primary completion date of 2033-01-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

According to the WHO report of 2021, approximately 10 million new cases were reported in 2020, of which 1 million occurred in the pediatric population. However, epidemiological data available on tuberculosis (TB) in pediatric age are extremely limited due to diagnostic challenges in this patient category. Furthermore, children are almost never included in national surveillance systems due to the lack of connections between individual pediatricians, pediatric hospitals, and national surveillance programs. It is therefore reasonable to assume that the disease may be significantly underestimated both in Italy and worldwide.

Eligibility Criteria

Inclusion Criteria: * Pediatric patients (0-18 years old) at the time of the initial observation * Patients affected by active and latent TB, as defined by the criteria of the World Health Organization * Patients exposed to TB who are found to be non-infected at the end of the window period * Informed consent signed by parents/legal guardian or by the patient who has reached the legal age of consent, assent of the minor Exclusion Criteria: * None

Contact & Investigator

Central Contact

Luisa Galli, MD

✉ luisa.galli@meyer.it

📞 +390555662439

Frequently Asked Questions

Who can join the NCT06289660 clinical trial?

This trial is open to participants of all sexes, aged 1 Week or older, up to 18 Years, studying Tuberculosis Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06289660 currently recruiting?

Yes, NCT06289660 is actively recruiting participants. Contact the research team at luisa.galli@meyer.it for enrollment information.

Where is the NCT06289660 trial being conducted?

This trial is being conducted at Florence, Italy, Bari, Italy, Belluno, Italy, Bologna, Italy and 11 additional locations.

Who is sponsoring the NCT06289660 clinical trial?

NCT06289660 is sponsored by Meyer Children's Hospital IRCCS. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology